EUVIMEDEUVIMED entdecken
Crossref

A Copper(I)-Azurin complex suppresses p53-mediated glycolysis to sensitize breast cancer to cuproptosis with MRI monitoring

Hui Wang, Yu Zhang, Dinghua Liu, Chang Liu, Shuang Wu, Zhuoyao Wu, Tianming Cui, Gongyao Yu, Yan Xu, Weitao Yang, Bingbo Zhang

Cancer Letters · 2026-11 · 660 · 218831

DOI: 10.1016/j.canlet.2026.218831 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2026-11. Verfasst von Hui Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Tongji Hospital, Shanghai Frontiers Science Center of Nanocatalytic Medicine, The Institute for Biomedical Engineering & Nan…. Hauptthemen laut MEDLINE: Azurin, Cuproptosis, Tumor Suppressor Protein p53, Glycolysis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities, Shanghai Municipal Health Commission, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Warburg effect drives cancer cells to rely preferentially on glycolysis, resulting in diminished mitochondrial oxidative phosphorylation (OXPHOS). This metabolic phenotype limits the ability of excess copper (Cu) ions to trigger cuproptosis in dysfunctional mitochondria, leading to suboptimal therapeutic outcomes. Therefore, remodeling tumor energy metabolism to counteract the Warburg effect represents a pivotal strategy to enhance cuproptosis efficacy. Herein, we developed a Cu(I)-stabilized metal-organic framework nanoplatform (CuTz-1) encapsulated by Azurin (CuTz-1@Azurin) as a cuproptosis sensitizer. Mechanistically, Azurin increases p53 protein levels by intercepting MDM2-mediated ubiquitin-proteasome degradation. Elevated p53 subsequently inhibits pyruvate kinase M2 (PKM2) activity, suppressing glycolysis, while simultaneously promoting mitochondrial OXPHOS-collectively shifting cellular metabolism from glycolysis toward mitochondrial respiration and sensitizing tumor cells to Cu-induced proteotoxic stress. In addition, CuTz-1@Azurin triggers oxidative stress via reactive oxygen species (ROS) generation and glutathione (GSH) depletion, which act together with p53-mediated apoptosis to suppress tumor growth. Meanwhile, the oxidation of Cu(I) to paramagnetic Cu(II) enables real-time monitoring of the therapeutic process by magnetic resonance imaging (MRI). Both in vitro and in vivo results demonstrate good antitumor performance of CuTz-1@Azurin. This study highlights the potential of Azurin-mediated metabolic regulation as a promising strategy to potentiate cuproptosis for combined cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AzurinCuproptosisTumor Suppressor Protein p53GlycolysisCopperBreast NeoplasmsHumansAnimalsFemaleMagnetic Resonance ImagingMiceMitochondriaCell Line, TumorApoptosisXenograft Model Antitumor AssaysReactive Oxygen SpeciesMetabolic ReprogrammingOxidative Stress

Stichwörter der Autor:innen

AzurinCuproptosisGlycolytic reprogrammingMagnetic resonance imagingp53

Substanzen

AzurinTumor Suppressor Protein p53CopperTP53 protein, humanReactive Oxygen Species

Autor:innen und Institutionen

  • Department of Radiology, Tongji Hospital, Shanghai Frontiers Science Center of Nanocatalytic Medicine, The Institute for Biomedical Engineering & Nano Science, School of Medicine, Tongji University, Shanghai, 200065, Ch…

Förderung

  • Fundamental Research Funds for the Central Universities
  • Shanghai Municipal Health Commission
  • National Natural Science Foundation of China

Zitieren

APA

Wang, H., Zhang, Y., Liu, D., Liu, C., Wu, S., Wu, Z., Cui, T., Yu, G., Xu, Y., Yang, W., & Zhang, B. (2026). A Copper(I)-Azurin complex suppresses p53-mediated glycolysis to sensitize breast cancer to cuproptosis with MRI monitoring. Cancer Letters, 660, 218831. https://doi.org/10.1016/j.canlet.2026.218831

Vancouver

Wang H, Zhang Y, Liu D, Liu C, Wu S, Wu Z, et al. A Copper(I)-Azurin complex suppresses p53-mediated glycolysis to sensitize breast cancer to cuproptosis with MRI monitoring. Cancer Letters. 2026;660:218831. doi:10.1016/j.canlet.2026.218831

BibTeX
@article{Wang2026,
  author = {Wang, Hui and Zhang, Yu and Liu, Dinghua and Liu, Chang and Wu, Shuang and Wu, Zhuoyao and Cui, Tianming and Yu, Gongyao and Xu, Yan and Yang, Weitao and Zhang, Bingbo},
  title = {A Copper(I)-Azurin complex suppresses p53-mediated glycolysis to sensitize breast cancer to cuproptosis with MRI monitoring},
  journal = {Cancer Letters},
  year = {2026},
  volume = {660},
  pages = {218831},
  doi = {10.1016/j.canlet.2026.218831}
}
Kostenlos starten →